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Abstract
Graduate medical education has traditionally focused on training future physicians to be outstanding clinicians with
basic and clinical science research skills. This focus has resulted in substantial knowledge gains, but a modest return
on investment based on direct improvements in clinical care. In today’s shifting healthcare landscape, a number of
important challenges must be overcome to not only improve the delivery of healthcare, but to prepare future
physicians to think outside the box, focus on and create healthcare innovations, and navigate the complex legal,
business and regulatory hurdles of bringing innovation to the bedside. We created an interdisciplinary and
experiential medical technology design competition to address these challenges and train medical students
interested in moving new and innovative clinical solutions to the forefront of medicine. Medical students were
partnered with business, law, design and engineering students to form interdisciplinary teams focused on developing
solutions to unmet clinical needs. Over the course of six months teams were provided access to clinical and industry
mentors, $500 prototyping funds, development facilities, and non-mandatory didactic lectures in ideation, design,
intellectual property, FDA regulatory requirements, prototyping, market analysis, business plan development and
capital acquisition. After four years of implementation, the program has supported 396 participants, seen the development
of 91 novel medical devices, and launched the formation of 24 new companies. From our perspective, medical education
programs that develop innovation training programs and shift incentives from purely traditional basic and clinical science
research to also include high-risk innovation will see increased student engagement in improving healthcare delivery and
an increase in the quality and quantity of innovative solutions to medical problems being brought to market.
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Background
Traditional clinical and basic science research forms the
foundation of medical care and medical education. Recog-
nized shortfalls in how graduate medical education has
been delivered have resulted in many medical schools
adopting a more integrated curricular approach to teach-
ing [1,2]. However, without the development of clinician-
driven innovation, many of the advances made through
these teaching approaches remain unrealized – often
never leaving the laboratory bench [3]. As the demand for
better and more cost effective health care quality and
delivery continues to increase – expensive, limited, and
time consuming traditional research programs are put
under greater scrutiny to produce outputs not necessarily
consistent with their primary goals [3,4]. Furthermore, the
current pathway for training clinician-researchers and
clinician-innovators is riddled with needs and challenges
[3,5-7]. Attempts at addressing these issues have included
combined degrees (MD/MBA), which between 2011 and
2012 alone, the number of MD/BMA programs increased
by 25%, as well as interdisciplinary programs such as
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Stanford Biodesign [8,9]. These programs are extremely
valuable but often require more time away from medical
education than most medical students will accept, and raise
the concern for drawing down the number of clinicians
who participate in clinical care in an environment with an
ever increasing need for more healthcare providers [8].
In the viewpoint, “Health Services Innovation: The
Time is Now”, Zuckerman et al. explicitly identified a
number of challenges to training a new generation of
clinician-innovators [3]: First, hospital and medical
school leadership need to value and promote under-
standing of systems of care and innovation; Second,
training in technical methods for innovation…will need
to come from nontraditional places – business, engineer-
ing, and design schools. Strategies from industry, such as
innovation challenges and “crowd sourcing”, will further
enhance development of new ideas; Third, the traditional
incentives in academia to reward publications and funding
for traditional research will need to be adjusted to include
incentives for clinician-innovators and to have greater
tolerance of risk because most innovations will fail.
Herein, we present our solution to bridge the gap in
clinician-innovation training. We provide data from a four–
year experience with a student-driven, experiential medical
device design competition, entitled Bench-to-Bedside, that
engages stakeholders at all levels to support a paradigm
shift in the driving incentives of medical education from
developing traditional clinician-researchers to developing
clinician-innovators. We believe this paradigm shift will
play a valuable role in translational research, which deals
with the awareness, acceptance and adoption of new tech-
nology, with adoption often being the most difficult compo-
nent [10]. Studies have shown clinical innovations built on
evidence-based medicine are more likely to be adopted
[11], and the speed of adoption is dependent on senior
management and clinical leadership [12]. By placing clinical
leadership, starting at the level of the medical student, at
the forefront of translational medicine through an interdis-
ciplinary innovation program we anticipate more clinical
innovations will be brought to market than programs built
solely on basic science research and/or healthcare manage-
ment. The program we have created addresses the main
innovation challenges identified by Zuckerman et al. [3],
provides a model for translational research implementation,
and gives us an experiential perspective we hope to share
with others.
The detailed outline of the organization, structure and
curriculum of the competition can be found in the
OPEN Conference Report [13]. In brief, medical students
were partnered with graduate students from business,
engineering, design and law, provided $500 in prototype
funding, and given 6 months to develop a solution to an
unmet clinical need, thus bridging the gap from discovery
to clinical delivery anticipated in translational research
[14]. The primary outcomes evaluated included yearly
participants, medical student participants, and teams. Sec-
ondary outcomes included devices developed, provisional
patents filed, utility patents filed, and LLCs formed. The
outcomes were evaluated from year-to-year totals. Success
was determined by an increasing number of secondary
outcomes from year to year. The initial recruitment goal
for the first year was five teams. Each of the clinician-
innovation training challenges were addressed as follows:
First challenge: establishing innovation value by medical
leadership
In June 2010, the Dean of the School of Medicine at the
University of Utah announced the creation of a new
Center for Medical Innovation to house the B2B compe-
tition, along with other newly developed University of
Utah medical innovation programs. The center formalized
partnerships between the College of Engineering, the
colleges in the Health Sciences Center, the School of
Business, the College of Law, and the ongoing Technology
Venture Development Program. The Center for Medical
Innovation managed outside sponsorship of the B2B
competition, financial support of student projects, and
established guidelines and resources to help prevent stu-
dents from entering into inappropriate and conflicting
agreements with outside pharmaceutical and medical
device companies.
Second challenge: developing nontraditional training –
business, engineering and design
Bench-to-Bedside was designed to leverage interdiscip-
linary education through the formation of entrepreneur-
ial teams composed of medical students, engineering
students, business students, and law students – who
form start-up companies (Table 1). The teams are given
the task of identifying an unmet clinical need, as well as
access to many resources including: university physicians
mentors, technology development funds, the Lassonde
Entrepreneurship Institute, and the Center for Medical
Innovation intellectual property and new venture law
fellows. Workshops are held covering clinical needs
identification, business plan development, prior art
searching, FDA regulatory compliance, engineering and
design prototyping, patent development, and term sheet
negotiations (Table 1) [13].
Third challenge, part A: applying strategies from industry
To provide further support and training, the Center for
Medical Innovation established an Industrial Board
composed of community leaders in the medical device
industry. Each team is paired with one of these leaders
as a mentor, who provides direction and advice through-
out the competition. Furthermore, at the end of the
competition, many of the mentors continue to educate
Loftus et al. Clinical and Translational Medicine  (2015) 4:15 Page 2 of 6
and support the teams through the commercialization
process.
Third challenge, part B: providing crowdsourcing and
milestone funding
While the primary purpose of the competition is to edu-
cate future clinician-innovators, a milestone-funding
program was established to promote continued develop-
ment of ideas in the years following completion of the
competition. B2B partnered with the University of Utah
Entrepreneur Club to provide ongoing financial support
to teams continuing beyond competition night. Student
teams make milestone pitches to the Entrepreneur Club,
which validates the ideas and determines financial
support needed to reach their next milestone. As ideas
are appropriately validated, B2B provides the funds ne-
cessary for teams to advance the commercialization of
their technologies.
Fourth challenge: adjustment of incentives
In order to better prepare medical students for a mean-
ingful career in medicine, the University of Utah School
of Medicine requires each medical student to complete a
scholarly activity – constituting a hypothesis based re-
search project. The basis of this requirement has roots
based on the incentives of academia to reward publica-
tions and funding for traditional research. After demon-
strating during the first three years of the competition
that most, if not all, of the clinical innovations were hy-
pothesis based, the Bench-to-Bedside student leadership
proposed to the University of Utah School of Medicine
curriculum committee a change to the scholarly activity
requirement to include clinical innovation. After three
attempts, and from support of the dean of the medical
school, the curriculum committee supported an adjust-
ment in its policy to accept medical device innovation as a
fulfillment of the scholarly activity requirement, along with
both clinical and basic science research. The University of
Utah School of Medicine determined that completion of
the Bench-to-Bedside program was adequate to replace
the traditional research project based on four principles:
First, the program allowed students to find and follow a
passion that helped distinguish them throughout medical
school and beyond. Second, students were able to develop
expertise in not only one or more areas of medicine, but
also in engineering, business, and law. Third, students
through the translational process were able to perform
inquiry-based research via needs-identification and design
iteration. Fourth, through milestone funding and the
awards night of the competition, students were able to
effectively communicate the rationale for and results of
their innovative activity. Through each of these principles
students were completing the same tasks of traditional re-
search, but instead of a publication at the end of the year,
they had a new innovation.
Outcomes and discussion
After four years of implementation, the competition
supported 396 participants (144 of which were medical
students) and 87 teams, which developed 91 new med-
ical devices and launched 24 new companies (Table 2).
A total of 55 provisional patents were filed, 15 of which
have made it to utility patents. Secondary outcomes in-
cluding devices developed, provisional patents filed, util-
ity patents filed, and LLCs formed increased 3.1, 1.3, 5,
and 12 fold, respectively, from the first year to the fourth
year of competition, demonstrating that as solutions to
Table 1 Nontraditional training: list of disciplines medical
students are exposed to via interdisciplinary teams, as
well as yearly workshops, in the Bench-to-Bedside
Competition
Medical student exposure to non-traditional training
By discipline (Team) By topic (Workshop)
Health Sciences: Clinical Need Identification
• Biomedical Informatics Business Plan Development
• Nursing Prior Art Searching
• Pharmacy FDA Regulations
• Exercise & Sports Science Prototyping
Business: Term Sheet Negotiation
• Business Administration Patent Development



















• Film & Media Arts
• English
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the initial four challenges identified by Zuckerman et al.
were applied, improved secondary outcomes were seen.
It was not until the adjustment of incentives in late 2013
allowing B2B projects to fulfill the scholarly activity re-
quirement, as well as the establishment of milestone fund-
ing to continuing teams and pairing of students with
industry mentors, that a marked increase in student
participation was observed. The number of medical stu-
dents participating in 2014 increased approximately 1.5
fold to a total of 53. Anecdotally, the increase in partici-
pating medical students led to a 2.5 fold increase in inter-
disciplinary student participation – the medical students
often being the crux of identifying true clinical needs and
maintaining teams.
With the establishment of milestone funding to continu-
ing teams and industry mentors, not only did new partici-
pants enter the competition, but students who competed in
previous years returned with advanced experience – in-
creasing the number of limited liability companies (LLCs)
and devices (Table 2). For a complete list of clinical prob-
lems and solutions developed by student teams over the
program’s history, as well as success stories for projects be-
ing adopted into market, please refer to our published com-
petition reports [15,16], as well as the Bench-to-Bedside
website for the most recent devices (http://healthsciences.
utah.edu/center-for-medical-innovation/students/bench-to-
bedside.php).
The B2B competition would have long remained a small
student event if the medical school leadership had not seen
the value of student innovation education. When the first
challenge of establishing value by medical leadership was
met and a center for medical innovation was established, it
became easier to develop a nontraditional training competi-
tion for medical students – which included business, engin-
eering, and design exposure.
Through the Center for Medical Innovation, industry-
university relationships were nurtured and applied to
students. Pairing of students with business mentors, pro-
viding milestone funding, and adjusting incentives to
support high-risk innovation showed exponential growth
of competition participants, medical devices produced,
limited liability companies, and patents.
While we have experienced extremely optimistic out-
comes in training a new generation of clinician-
innovators, we recognize there is yet a long way to travel
in the paradigm shift from the incentives of academia to
reward publications and funding for traditional research
to reward often high risk innovations. Some of these
initial steps include collecting data concerning percep-
tions of innovation importance from residency programs
and student interviews. Furthermore, the developed de-
vices from the B2B Competition will require long-term
follow up to evaluate the true worth of an extracurricu-
lar interdisciplinary program. Students developing their
education through hands-on nontraditional learning ex-
periences will need to be assessed compared to trad-
itional classroom learning for knowledge output and
capability to succeed in the clinical environment. Fur-
thermore, evaluation of reasons for student participation
will be continuously required.
Although these next steps certainly exist, their un-
known and ongoing answers do not diminish the need
to truly develop a new generation of clinician innovators.
Furthermore, they do not distract from the program’s
highly positive innovation outcomes. While many busi-
ness competitions exist for students, many of which can
be found on istart.org, we are unaware of any competi-
tion that is focused primarily on medical innovation and
the training of clinician innovators through an interdis-
ciplinary approach involving business, law, engineering,
and design.
Conclusion
Our four-year outcomes data has validated the program’s
approach as a model for training future clinician-
innovators and as a benchmark translational research
implementation program, resulting in 24 new companies
and the creation of 91 new medical devices. Furthermore,
our outcomes validated our solutions to the challenges
proposed by Zuckerman et al. We believe there are several
critical lessons learned from our experience that can be
applied to other future programs, all of which will help
bridge the gap of training clinician innovators and bring-
ing solutions from the bench to the bedside.
First Lesson: a subset of medical students is inherently in-
terested in non-traditional training (business, engineering,
design). When medical school leadership value medical
innovation by creating opportunities, such as innovation
centers and competitions, as well as establishing resources
Table 2 Participant, team, device, patent, and company
totals for each year of the competition
Competition results
2011 2012 2013 2014 Totals
Yearly
Participants
76 (19%) 57 (14%) 74 (19%) 189 (48%) 396 (100%)
Medical Student
Participants
32 (22%) 23 (16%) 36 (25%) 53 (37%) 144 (100%)
Teams 13 (15%) 14 (16%) 18 (21%) 42 (48%) 87 (100%)
Devices
Developed
14 (15%) 14 (15%) 20 (22%) 43 (48%) 91 (100%)
Provisional
Patents Filed
12 (22%) 13 (24%) 14 (25%) 16 (29%) 55 (100%)
Utility Patents
Filed
1 (7%) 4 (27%) 5 (33%) 5 (33%) 15 (100%)
LLCs Formed 1 (4%) 4 (17%) 7 (29%) 12 (50%) 24 (100%)
Percentages of the total are listed. LLCs = Limited Liability Companies.
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for product development, their initial setup risk will be
compensated by increased student interest and, linearly, in-
creased student outputs. Furthermore, these centers and
competitions will serve as the basis for business, engineer-
ing, and design training of future clinician-innovators.
Second Lesson: opening the doorway for students to
interact with industry professionals in a safe manner that
does not compromise or conflict with their education
provides hands-on innovation training that cannot be
taught in the classroom, creates an invaluable net-
work of university-industry connections, and increases
the likelihood of medical solutions succeeding – as
evidenced by B2B’s increase in both limited liability
companies and patents during the fourth year of the
competition. The benefits of such university-industry
connections are not new [17], however their exten-
sion to the current training of future clinicians shows
extreme promise towards student retention, project
advancement, and the creation of long-term economic
benefit.
Third Lesson: the most important factor for increasing
participation in a non-mandatory innovation-training
program was to move the incentive focus from trad-
itional research, including publishing papers, to poten-
tially high-risk experimental innovation. In the most
recent year of the competition, this adjustment to the
University of Utah’s scholarly activity requirement has
close to doubled the number of medical student partici-
pants (Table 2). In a “publish or perish” environment,
hospital and medical curriculum leadership, must be
willing to redefine what makes a great student, resident,
or clinician when innovations fail [18]. By having a
scholarly activity requirement that can be met, by not
only basic and clinical science research and publications,
but also development of a new medical device – even if
the device fails in the market – a student can have confi-
dence that their long-term residency and employment
risks, which often appear dependent on publications in-
stead of innovations, can be mitigated.
We agree with Zuckerman et al. wherein they stated
[3], “A new generation of trained clinician-innovators is
needed to identify opportunities for innovation when
others see problems and frustration. These clinicians will
need support to initiate the small but important changes
that may ultimately lead to larger transformations in
health care”. The lessons we have learned, herein, pro-
vide many of the starting points for initiation of these
small but important changes. Their application will open
the doorway for an innovation-led paradigm shift of the
up and coming generation towards better healthcare
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